National Rotavirus Surveillance Program annual report, 2004-05
DOI:
https://doi.org/10.33321/cdi.2006.30.8Keywords:
rotavirus, annual report, disease surveillanceAbstract
The National Rotavirus Reference Centre together with collaborating laboratories Australia-wide has conducted rotavirus surveillance since June 1999. This report describes the serotypes of rotavirus strains responsible for the hospitalisation of children with acute gastroenteritis during the period 1 July 2004 to 30 June 2005. Six hundred and twelve faecal samples from across Australia were examined using monoclonal antibody immunoassays, reverse transcription-polymerase chain reaction and polyacrylamide gel analysis. Serotype G1 was the dominant serotype nationally, representing 48.3 per cent of all strains, followed by serotype G3 (36.7%) and serotype G9 (6.9%). As in previous years, there was substantial geographic variation in the prevalence of rotavirus serotypes. Commun Dis Intell 2006;30:133–136.
Downloads
References
Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003;9:565–572.
Carlin JB, Chondros P, Masendycz P, Bugg H, Bishop RF, Barnes GL. Rotavirus infection and rates of hospitalisation for acute gastroenteritis in young children in Australia, 1993–1996. Med J Aust 1998;169:252–256.
Glass RI, Bresee JS, Parashar UD, Jiang B, Gentsch J. The future of rotavirus vaccines: a major setback leads to new opportunities. Lancet 2004;363:1547–1550.
Kirkwood CD, Bogdanovic-Sakran N, Bishop R, Barnes G. Report of Australian Rotavirus Surveillance Program, 2003/2004. Commun Dis Intell 2004;28:481–485.
Kirkwood CD, Bogdanovic-Sakran N, Clark R, Bishop RF, Barnes GL. Report of Australian Rotavirus Surveillance Program, 2002/2003. Commun Dis Intell 2003;27:492–495.
Coulson B, Unicomb L, Pitson G, Bishop R. Simple and specific enzyme immunoassay using monoclonal antibodies for serotyping human rotaviruses. J Clin Microbiol 1987;25: 509–515.
Gouvea V, Glass RI, Woods P, Taniguchi K, Clark HF, Forrester B, et al. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 1990;28:276–282.
Masendycz P, Bogdanovic-Sakran N, Palombo E, Bishop R, Barnes G. Annual report of the Rotavirus Surveillance Program, 1999/2000. Commun Dis Intell 2000;24:195–198.
Masendycz P, Bogdanovic-Sakran N, Kirkwood C, Bishop R, Barnes G. Report of the Rotavirus Surveillance Program, 2000/2001. Commun Dis Intell 2001;25:143–146.
Gentsch JR, Laird AR, Biefelt B, Griffin DD, Banyau K, Ramachandran M, et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis 2005;192:S146–S159.
Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005;15:29–56.
Palombo EA, Masendycz PJ, Bugg HV, Bogdanovic-Sakran N, Barnes GL, Bishop RF. Emergence of serotype G9 human rotaviruses in Australia. J Clin Microbiol 2000;38:1305–1306.
Kirkwood C, Bogdanovic-Sakran N, Clark R, Masendycz P, Bishop R, Barnes G. Report of Australian Rotavirus Surveillance Program, 2001/2002. Commun Dis Intell 2002;26:537–540.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2006 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
